{"id":86642,"date":"2024-11-03T04:16:05","date_gmt":"2024-11-03T04:16:05","guid":{"rendered":"https:\/\/pakistaninewspaperlist.com\/news\/deadline-alert-faruqi-faruqi-llp-encourages-investors-of-edwards-lifesciences-corporation-to-contact-us-to-have-their-losses-evaluated-today\/"},"modified":"2024-11-03T04:16:05","modified_gmt":"2024-11-03T04:16:05","slug":"deadline-alert-faruqi-faruqi-llp-encourages-investors-of-edwards-lifesciences-corporation-to-contact-us-to-have-their-losses-evaluated-today","status":"publish","type":"post","link":"https:\/\/pakistaninewspaperlist.com\/news\/deadline-alert-faruqi-faruqi-llp-encourages-investors-of-edwards-lifesciences-corporation-to-contact-us-to-have-their-losses-evaluated-today\/","title":{"rendered":"DEADLINE ALERT: Faruqi &#038; Faruqi, LLP Encourages Investors of Edwards Lifesciences Corporation to Contact Us to Have Their Losses Evaluated Today"},"content":{"rendered":"<div id=\"main-body-container\" itemprop=\"articleBody\">\n<p><strong>Faruqi &amp; Faruqi, LLP Securities Litigation Partner <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=D8azg-NFMCYlklDf9tDGRrhOKX3NrCAMbXdy5N-lK0qt56E2YLRRCz0jWzldHXC9dqbxE-su-p1tw3BG17EyLxpGVlBek9j9DgTcEYe9ruU6OHRoa9cxbzFK5C_PtlrhJrofDFEbYYIZ0J_FCQgoNw==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><strong>James (Josh) Wilson<\/strong><\/a><strong> Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options<\/strong><\/p>\n<p><strong>If you suffered losses exceeding $100,000 in <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dData8ns7_OvNmfcdUk-HjorHeuPpqWaCFaUy5T2PE8_13ReOa3ifW9sCFXeGPQOhsxbA3H6T8-Oatk95ZLsVQ==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><strong>Edwards<\/strong><\/a><strong> between February 6, 2024 and July 24, 2024 <\/strong>and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner <strong>Josh Wilson directly <\/strong>at <strong>877-247-4292 <\/strong>or <strong>212-983-9330 (Ext. 1310)<\/strong>.<\/p>\n<p align=\"center\"><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NePZSeimZ4YUbaBkjQRGW6Y4-Yj5viz_3VMPvna34kN_KSNmk0cP46Qh9It_PVlQDZapXpoCdvGbXyzdmMEx3oNCpH8af8vEuMzdCC-ZdOuIjlgGyc3dVixL_MB_xvXu\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><strong>[Click here to submit your transactions]<\/strong><\/a><\/p>\n<p align=\"center\"><\/p>\n<p>NEW YORK, Nov.  02, 2024  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fzpRODIznOOE7Ve9yyaiJJn6LFjHI5k-wvGJQWDRn-6TxdcabtyFewIknBOIMWMu3xPQZsVvM5pwignobPx9aMyDN2wFw1w1QCa-fag8r78=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Faruqi &amp; Faruqi, LLP\">Faruqi &amp; Faruqi, LLP<\/a>, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation (\u201cEdwards\u201d or the \u201cCompany\u201d) (NYSE: EW) and reminds investors of the <strong>December 13, 2024 deadline<\/strong> to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.<\/p>\n<p>Faruqi &amp; Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NnRzLZ9t7yOZfbEHqpUJXDV9THWPXH3JlO8bbz8kkLFXFgv6iJs_8wh8_-8pX9m1Un6se0ZaSNZA3P4Qqonad-YquUVVgrj7TcdVWz4un9E=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.faruqilaw.com\">www.faruqilaw.com<\/a>.<\/p>\n<p>As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and\/or misleading statements and\/or failing to disclose that defendants provided investors with material information concerning Edwards\u2019 expected revenue for the fiscal year 2024, particularly as it related to the growth of the Company\u2019s core product, Transcatheter Aortic Valve Replacement (\u201cTAVR\u201d). Defendants\u2019 statements included, among other things, strong commitment to the TAVR platform, confidence in the Company\u2019s ability to capitalize on a subset of untreated patients through scaling of its various patient activation activities, and continued claims of significant demand in allegedly lower-penetrated markets.<\/p>\n<p>On July 24, 2024, Edwards unveiled below-expectation financial results for the second quarter of fiscal 2024 and, in particular, slashed its revenue guidance for the TAVR platform for the full fiscal year 2024. The Company attributed the TAVR setback on the \u201ccontinued growth and expansion of structural heart therapies \u2026 [which] put pressure on hospital workflows.\u201d Investors understood this to mean that developments in new procedures, including Defendant\u2019s own Transcatheter Mitral and Tricuspid Therapies (\u201cTMTT\u201d), put significant strain on hospital structural heart teams such that they were underutilizing TAVR, despite the Company\u2019s continued claim of a significantly undertreated patient population. Moreover, the Company announced three acquisitions during the second quarter designed to embolden their treatments alternative to TAVR, suggesting further that the company was aware of the potential for the TAVR platform\u2019s decelerated growth. Investors and analysts reacted immediately to Edwards\u2019 revelations. The price of Edwards\u2019 common stock declined dramatically. From a closing market price of $86.95 per share on July 24, 2024, Edwards\u2019 stock price fell to $59.70 per share on July 25, 2024, a decline of about 31.34% in the span of just a single day.<\/p>\n<p>The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.\u00a0\u00a0<\/p>\n<p>Faruqi &amp; Faruqi, LLP also encourages anyone with information regarding Edwards\u2019 conduct to contact the firm, including whistleblowers, former employees, shareholders and others.<\/p>\n<p>To learn more about the <strong>Edwards Lifesciences Corporation<\/strong> class action, go to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NnRzLZ9t7yOZfbEHqpUJXM0cct2uXejVxFP-jWsHS0oNUF-zL-gMiQCED2xnObD4iTYz_okVLNBZtr3JrJwSTWFaNDtoJKrlOzHt7XENPCQ=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><strong>www.faruqilaw.com\/EW<\/strong><\/a> or <strong>call<\/strong> Faruqi &amp; Faruqi partner <strong>Josh Wilson directly <\/strong>at <strong>877-247-4292 <\/strong>or <strong>212-983-9330 (Ext. 1310)<\/strong>.<\/p>\n<p>Follow us for updates on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Tk3nbMBWH6FK_IaeLdMHRORlpM5qAosF8IVntJVa76BJOgt-9KLu7wXO16RSLXj05V6Q35n3M3ZjOxLiwYMeTL1bkmxsefCg7naZV0wSgjeWlqZMB1lexkQHKrJzYKzQ\" rel=\"nofollow noopener\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>, on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uQgMAMiu9DcWLtKIgW2yYoAysdOX0HAyh9S0VtRjM1N4Dv8CGvTIhpkMzwH1Wkzu2UMZ5a_GJgWggxzlfsCYOQ==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"X\">X<\/a>, or on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RY_zA8QSIymZOYlpQ75M8vAa2jNIC3_uX4TUkWLkhLsoLcXBod-_S8ZnmyvaygpTYly6Kbk90MRwFGDV6DHckrA3Q2QZ38F-alo6wouVmjE=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Facebook\">Facebook<\/a>.<\/p>\n<p>Attorney Advertising. The law firm responsible for this advertisement is Faruqi &amp; Faruqi, LLP (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NnRzLZ9t7yOZfbEHqpUJXMvoR02UfTOYnptL_LZQ7dhCz6hASjidRkLZj9oMXyfRYN19xO-1DLHBYeiKTPXCpLFpm4EhFZlWOOIyjGxzG_Y=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.faruqilaw.com\">www.faruqilaw.com<\/a>). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NzNkOGI5MzMtNDc1NS00Y2YxLWE2ZDYtMmQ0MjQyZGRhMGJhLTEwMjkyMDk=\/tiny\/Faruqi-Faruqi-LLP.png\" referrerpolicy=\"no-referrer-when-downgrade\"\/>\n            <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi &amp; Faruqi [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":86643,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/8628babf-2ea4-4b8a-a60b-260db109bfa2","fifu_image_alt":"","footnotes":""},"categories":[208],"tags":[],"class_list":["post-86642","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts\/86642","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/comments?post=86642"}],"version-history":[{"count":0,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/posts\/86642\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/media\/86643"}],"wp:attachment":[{"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/media?parent=86642"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/categories?post=86642"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pakistaninewspaperlist.com\/news\/wp-json\/wp\/v2\/tags?post=86642"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}